Cell of origin (COO), BCL2/MYC status and IPI define a group of patients with Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis in a real-world clinical setting

Autor: Bettelli, Stefania, Marcheselli, Raffaella, Pozzi, Samantha, Marcheselli, Luigi, Papotti, Robel, Forti, Elisa, Cox, M. Christina Christina, Di Napoli, Arianna, Tadmor, Tamar, Mansueto, Giovanna R., Musto, Pellegrino, Flenghi, Leonardo, Quintini, Martina, Galimberti, Sara, Lalinga, Vittoria, Donati, Valentina, Maiorana, Antonino, Polliack, Aaron, Sacchi, Stefano *
Zdroj: In Leukemia Research May 2021 104
Databáze: ScienceDirect